Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
Eur J Haematol
; 106(3): 433-436, 2021 Mar.
Article
in En
| MEDLINE
| ID: mdl-33259093
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thalidomide
/
Multiple Myeloma
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Eur J Haematol
Journal subject:
HEMATOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos